Author: healthadmin
Myocardial ischemia, the leading cause of heart attacks, remains a leading cause of death and disability worldwide. Delays in diagnosis are directly correlated with increased myocardial necrosis, increased complication rates, and increased mortality. Although conventional 12-lead ECG is the clinical gold standard for ischemia detection, its transient nature prevents it from capturing transient and unpredictable ischemic episodes during continuous monitoring in the outpatient setting. Although wearable ECG devices are excellent at detecting arrhythmias such as atrial fibrillation (>95% sensitivity), their usefulness in ischemia detection has long been limited by subtle multiscale temporal changes in the ECG waveform that indicate the…
Daily fish oil supplements may help lower the risk of serious cardiovascular complications in people with kidney failure and undergoing dialysis. The findings come from a large-scale international clinical trial co-led in Australia by Monash Health and Monash University’s Faculty of Clinical Sciences. The study, known as the PISCES trial, included 1,228 participants receiving dialysis treatment at 26 centers in Australia and Canada. The results were presented at American Society of Nephrology Kidney Week 2025. New England Medical Journal. Large clinical trial showed 43% reduction in serious cardiac events Participants who took 4 grams of fish oil daily had significantly…
The human body relies on carefully orchestrated genetic instructions that guide how cells grow and function. Cancer can occur when these instructions are disrupted. Over time, cells accumulate genetic mistakes that allow them to escape the normal controls that limit their growth and division. One of the earliest warning signs in this process is the presence of chromosomal abnormalities, including changes in chromosome number or structure. These defects can cause healthy cells to become cancerous. Researchers from the Kobel Group at EMBL Heidelberg have now developed a powerful AI-based tool to help scientists investigate how these chromosomal abnormalities arise. By…
For more than a decade, Hino Motors Corporation imported and sold more than 105,000 vehicles and engines with misleading or fabricated emissions data until an inspection by the Environmental Protection Agency uncovered an emissions fraud scheme. The lawsuit requires the Toyota subsidiary to plead guilty and agree to pay more than $1.6 billion in fines over five years and forfeit $1 billion in profits from illegal sales. The EPA touted the case Monday in its Enforcement and Compliance Assurance Results for the fiscal year ending Sept. 30, 2025, and claimed in a press release that the agency closed more cases…
Researchers at Oregon Health & Science University have developed a new molecule that may open the door to treating difficult cases of triple-negative breast cancer. Triple-negative breast cancer is a progressive disease for which there are currently few effective treatments. In a study published in a journal cell report medicineThe research team describes how an experimental molecule called SU212 blocks an enzyme that plays a key role in cancer progression. The findings came from experiments using humanized mouse models designed to mimic human disease. “This is an important advance in the treatment of triple-negative breast cancer,” said lead author Dr.…
CVS Health is investing in digital health and patient engagement technology across the enterprise, including a partnership with Simile to leverage “agent twins” to test and pilot new programs. The company built these digital twins based on 2.9 million agreed responses from a group of more than 400,000 people, representing responses across more than 200 behavioral scenarios. This allows the AI version to act as an accurate stand-in for the people it is based on. By deploying these digital agents, the company’s developers can test workflows, messages, and other services and receive feedback that reflects the behavior of real people.…
Sandoz didn’t mince words about the huge but largely untapped opportunity facing biosimilar makers, as dozens of branded drugs edge toward the patent cliff over the next decade. Now, as part of its efforts to take full advantage of what the company recently referred to as a potential “golden decade” of affordable medicines beyond 2030, Sandoz is further focusing on its biosimilars business with plans to launch a specialized division that will operate separately from the rest of the company’s small molecule generics division. The new biosimilars division will focus on the development, manufacturing and supply of mimicking biologics and…
A recent analysis of more than 200,000 people found that the relative length of the index and ring fingers was associated with sexual orientation. This study suggests that the hormones a fetus is exposed to in the womb determine its physical development and who a person is attracted to later in life. These results were recently published in the journal frontiers of psychology. Before birth, the developing fetus is exposed to varying levels of sex hormones. These hormones, such as testosterone and estrogen, play a central role in shaping the body’s physical differences. They also help regulate how genes are…
AbbVie CEO Robert Michael will be paid $32.5 million in 2025, his second year on the job, a significant 75% increase from his first year, solidifying his position as one of the highest-paid executives in the biopharmaceutical industry. Michael is the second CEO at AbbVie to take over the top job at the Illinois drugmaker after Richard Gonzalez’s 11-year tenure as CEO ends in 2024. Michael, a longtime AbbVie executive, has picked up immediately where Gonzalez left off by refocusing the company’s flagship immunology portfolio on growth engines SkyRigi and Rinvoke following the loss of exclusivity for long-time top seller…
Serious diseases that affect the transparent part of the eye called the cornea are very difficult to treat because this structure has no blood vessels and little ability to regenerate or repair. Many patients with serious corneal conditions can only be treated with a transplant, in which the damaged cornea is removed and replaced with a healthy cornea from another person who has donated the organ. Now, researchers from the Tissue Engineering Group of the Department of Histology, Faculty of Medicine, University of Granada, and the ibs.GRANADA Biomedical Research Institute have created highly biocompatible, resistant, and transparent corneal implants from…